3-(cyclopentyloxy)-19-nor-17alpha-pregna-3,5-dien-20-yn-17-yl acetate
- CAS NO.：3000-39-3
- Empirical Formula: C27H36O3
- Molecular Weight: 408.57294
- MDL number: MFCD00867867
- EINECS: 221-078-4
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-05-04 17:34:37
What is 3-(cyclopentyloxy)-19-nor-17alpha-pregna-3,5-dien-20-yn-17-yl acetate ?
The Uses of 3-(cyclopentyloxy)-19-nor-17alpha-pregna-3,5-dien-20-yn-17-yl acetate
Progestin.
Definition
ChEBI: Quingestanol acetate is a steroid ester.
Properties of 3-(cyclopentyloxy)-19-nor-17alpha-pregna-3,5-dien-20-yn-17-yl acetate
| Melting point: | 183°C |
| Boiling point: | 469.08°C (rough estimate) |
| Density | 1.0870 (rough estimate) |
| refractive index | 1.4700 (estimate) |
Safety information for 3-(cyclopentyloxy)-19-nor-17alpha-pregna-3,5-dien-20-yn-17-yl acetate
Computed Descriptors for 3-(cyclopentyloxy)-19-nor-17alpha-pregna-3,5-dien-20-yn-17-yl acetate
New Products
ALUMINIUM IODIDE 100 GM BUFFER CAPSULE PH 7.0 - 10 CAP BUFFER SOLUTION PH 9.5 (BORATE) EZEE BLUE GEL STAINER BORAX CARMINE (GRENACHERS ALCOHOLIC) POTASSIUM IODATE - IODIDE SOLN 0.1 N Dabigatran Acyl-O3-D-Glucuronide Trifluoroacetic Acid Salt Isofolic Acid Dabigatran 2-O-acylglucuronide metabolite Dabigatran Acyl-?-D- glucuronide Trifluroacetic Acid Erythromycin EP Impurity A Desloratidine Related Compound ARelated products of tetrahydrofuran
You may like
-
Dabigatran Acyl-O2-D-Glucuronide Trifluoroacetic Acid SaltView Details -
Dechloro DesloratadineView Details -
Dehydro DesloratadineView Details -
Edoxaban Impurity 57View Details
2089454-69-1 -
Eltrombopag N-Oxide ImpurityView Details
2734533-17-4 -
Empagliflozin Bromo ImpurityView Details -
Glycopyrronium Bromide EP Impurity IView Details
1404617-94-2 -
Ipratropium EP Impurity BView Details
58073-59-9
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.